ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Social Media
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
29 Sep 2020

Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue

Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with the ove...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Sep 2020

Acarix genomför riktad nyemission av aktier till garanter i samband med den övertecknade företrädesemissionen

Pressmeddelande Malmö, Sverige, 29 september 2020 Acarix genomför riktad nyemission av aktier till garanter i samband med den överteck...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2020

Acarix announce final outcome in oversubscribed rights issue

Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB ("Acarix&...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2020

Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 11 september 2020 Acarix offentliggör slutgiltigt utfall i övertecknad företrädesemissionAcarix AB (&#...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix offentliggör preliminärt utfall i övertecknad företrädesemission

Pressmeddelande Malmö, Sverige, 9 september 2020 Acarix offentliggör preliminärt utfall i övertecknad företrädesemission INSIDERINFOR...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Sep 2020

Acarix announces preliminary outcome in oversubscribed rights issue

Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMATION:...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix decides on a guaranteed rights issue of approximately SEK 56 million

Press release Malmö, Sweden July 15, 2020 Acarix decides on a guaranteed rights issue of approximately SEK 56 million The board of di...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK

Pressmeddelande Malmö, Sverige, 15 juli 2020 Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK Styrelsen i Acarix AB ...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Oct 2019

The subscription period in Acarix’ rights issue commence today

Press release Malmö, 9 October 2019 The subscription period in Acarix' rights issue commence today The board of directors of Ac...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Oct 2019

Idag inleds teckningsperioden i Acarix företrädesemission

Pressmeddelande  Malmö, 9 oktober 2019 Idag inleds teckningsperioden i Acarix företrädesemission Styrelsen i Acarix AB ("Acari...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpansion

Pressmeddelande  Malmö, 25 september 2019 Acarix genomför företrädesemission om cirka 51,8 MSEK för att finansiera ökad marknadsexpa...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased ...
Continue reading
  • 1
  • 2
  • 3
  • 4
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • News
  • Press
  • Events
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2023. All rights reserved V5

  • Products
    • Background
      • What is Coronary Artery Disease
      • Diagnosing CAD
    • About the product
      • The Cadscor System
      • How Does it Work
  • Resources
    • Testimonial
      • HCP Stories
      • Patients Stories
    • References
      • Clinical Studies
      • Downloads (US)
      • Downloads (EU)
    • Support
      • Training
      • Faq
      • Reimbursement
    • Physician Locator
      • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
      • About Acarix
      • Leadership
      • Join The Team
    • Get in touch
      • Contact Us
      • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.